重组人脑利钠肽是模拟内源性B型钠尿肽发挥生理作用的。
The recombinant human B-type natriuretic peptide produces physiological effects by imitating endogenous B-type natriuretic peptide.
结论：重组人脑利钠肽治疗慢性心力衰竭安全有效，值得临床推广。
Conclusion: Recombinant human brain natriuretic peptide safe and effective treatment of chronic heart failure, worth clinical promotion.
结论：早期重组人脑利钠肽治疗急性心肌梗死可以有效改善心脏功能。
Conclusion: Early treatment with recombinant human brain natriuretic peptide can effectively improve cardiac function in rats with acute myocardial infarction.
目的探讨重组人脑利钠肽治疗超高龄充血性心力衰竭患者的临床疗效及安全性。
Objective To study the clinical efficacy and safety of recombinant human brain natriuretic peptide(rhBNP) in treatment on super - elderly patients with congestive heart failure.
静脉注射重组人脑利钠肽能迅速降低急性心力衰竭患者的肺毛细血管楔压，缓解呼吸困难症状，改善预后。
Intravenous recombinant human B-type natriuretic peptide can quickly degrade pulmonary capillary wedge pressure, relieve dyspnea, and improve a patient's prognosis.
静脉注射重组人脑利钠肽能迅速降低急性心力衰竭患者的肺毛细血管楔压，缓解呼吸困难症状，改善预后。
Intravenous recombinant human B-type natriuretic peptide can quickly degrade pulmonary capillary wedge pressure, relieve dyspnea, and improve a patient's prognosis.
应用推荐